Dr. Joshua Davyd Fox, MD

Dr. Fox practices at Deborah Longwill DO PA in Pinecrest, Florida.

Dr. Fox's NPI, 1316309586, was assigned on March 25, 2016. Dr. Fox graduated from University of Miami, Miller School of Medicine in 2016. Dr. Fox holds Florida license ME143981.

Dr. Fox's primary practice is Deborah Longwill DO PA, at 7700 Sw 104th St, Pinecrest, FL 33156 in Miami-Dade County. The practice phone is (305) 279-7546.

Dr. Fox's primary practice is Deborah Longwill DO PA in Pinecrest, Florida. The medical group on file is Miami Center for Dermatology. Dmand AI also links Dr. Fox to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fox practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Fox's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Fox is board certified in dermatology by the American Board of Dermatology. Dr. Fox is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Fox treats.

CMS data shows 3,298 Medicare services from Dr. Fox across 21 procedure codes in 2024, for 395 Medicare patients. Medicare paid $403,352 for them. Every service was in an office.

CMS counts 395 Medicare patients who saw Dr. Fox in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fox's median patient age at 49, with 50% women.

In 2024, Dr. Fox wrote 621 Medicare Part D claims for 225 patients. 97% of them were for generic drugs. CMS names the drug for 512 of them, across 13 drugs with 11 or more claims each, at $73,210 in total drug cost. In 2023, CMS named 370 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fox for performance year 2024, reported as part of a group. Dr. Fox accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fox as offering telehealth. CMS counts 668 procedures of removal of skin lesions by Dr. Fox, more than 89% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Fox, published from 2015 to 2021. 2020 was the busiest year, with 4. The most frequent topics are Wound Healing, Pilot Projects and Skin Neoplasms. Dr. Fox has published most often in JAMA Dermatol. Dr. Fox's most frequent co-authors are Robert S. Kirsner, MD, Ingrid Herskovitz, MD and Jeremy Brandon Freedman, MD.

CMS Open Payments shows 124 general payments to Dr. Fox from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Organogenesis Inc. paid the most, $650.

Dr. Fox graduated from University of Miami, Miller School of Medicine in 2016.

Dr. Fox is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.